TABLE 2.
Clinical features of patientsa
| Clinical feature | Value for:
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| CLD patients (n = 34)
|
Patients with HCC (n = 21)
|
Patients without HCC (n = 13)
|
|||||||
| SEN-V positive (n = 25) | SEN-V negative (n = 9) | P | SEN-V positive (n = 16) | SEN-V negative (n = 5) | P | SEN-V positive (n = 9) | SEN-V negative (n = 4) | P | |
| Age | 64 ± 12 | 66 ± 9 | 0.74 | 67 ± 10 | 70 ± 8 | 0.69 | 61 ± 15 | 61 ± 8 | 0.77 |
| Sex (no. of M/no. of F) | 22/3 | 7/2 | 0.59 | 15/1 | 3/2 | 0.13 | 7/2 | 4/0 | > 0.99 |
| Serum albumin level (g/dl) | 3.6 ± 0.5 | 3.5 ± 0.4 | 0.59 | 3.3 ± 0.6 | 3.4 ± 0.4 | 0.62 | 3.8 ± 0.4 | 3.7 ± 0.6 | 0.84 |
| Total bilirubin level (mg/dl) | 1.0 ± 0.8 | 1.1 ± 0.7 | 0.91 | 1.3 ± 0.9 | 1.4 ± 0.7 | 0.55 | 0.9 ± 0.6 | 1.0 ± 0.7 | 0.68 |
| AST (IU/liter) | 45 ± 21 | 54 ± 24 | 0.29 | 47 ± 21 | 56 ± 34 | 0.78 | 41 ± 21 | 52 ± 6 | 0.82 |
| ALT (IU/liter) | 41 ± 292 | 38 ± 20 | 0.74 | 42 ± 30 | 39 ± 25 | 0.66 | 40 ± 31 | 36 ± 13 | 0.62 |
| ICG R15 test result (%) | 19 ± 11 | 21 ± 6 | 0.75 | 20 ± 11 | 21 ± 6 | 0.87 | |||
| Platelet count (10,000/μl) | 12.7 ± 5.0 | 11.4 ± 5.4 | 0.53 | 13.0 ± 4.9 | 14.4 ± 2.7 | 0.48 | 11.9 ± 5.5 | 7.6 ± 5.8 | 0.28 |
| BTF historyb | 6/23 (26) | 2/8 (25) | > 0.99 | 4/16 (25) | 0/5 (0) | 0.53 | 2/7 (29) | 2/3 (67) | 0.50 |
| Alcohol use historyb | 14/21 (67) | 4/9 (44) | 0.22 | 12/15 (80) | 2/5 (40) | 0.13 | 2/6 (33) | 1/3 (33) | > 0.99 |
| TTV positiveb | 7/25 (28) | 1/9 (11) | 0.40 | 3/16 (19) | 1/5 (20) | > 0.99 | 4/9 (44) | 0/4 (0) | 0.23 |
a
Data are expressed as the means ± standard deviations unless indicated otherwise. Abbreviations: M, male; F, female; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BTF, blood transfusion.
b
The data represent the number of patients positive/number of patients tested (percent).